Spots Global Cancer Trial Database for act001
Every month we try and update this database with for act001 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme | NCT05053880 | Recurrent Gliob... | ACT001 ACT001 + Pembro... | 18 Years - | Accendatech USA Inc. | |
A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme | NCT05053880 | Recurrent Gliob... | ACT001 ACT001 + Pembro... | 18 Years - | Accendatech USA Inc. | |
A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme | NCT05053880 | Recurrent Gliob... | ACT001 ACT001 + Pembro... | 18 Years - | Accendatech USA Inc. |